Table 1. Clinical information of 32 surgical patients with mTLE and 18 controls included for analysis of plasma miR-153 level.
| mTLE group | Controls | |
|---|---|---|
| Number | 32 | 18 |
| Gender (M/F) | 19/13 | 12/6 |
| Mean age (years) | 24.94 ± 11.73 | 27.56 ± 12.46 |
| Epilepsy duration | 11.50 ± 5.20 | — |
| Seizure type | ||
| CPS | 3 (9.4%) | — |
| sGTCS | 11 (34.4%) | — |
| SPS/CPS + sGTCS | 18 (56.3%) | — |
| AEDs intake | ||
| Two AEDs | 9 (28.1%) | — |
| Three AEDs | 20 (62.5%) | — |
| Four or more AEDs | 3 (9.4%) | — |
The control group includes 5 cases with head trauma and 13 cases with cerebral hemorrhage. SPS: simple partial seizure; CPS: complex partial seizure; sGTCS: secondary generalized tonic-clonic seizure; AEDs: anti-epileptic drugs. AEDs used by patients include: phenobarbitone, phenothiazine, carbamazepine, lamotrigine, levetiracetam, valproate acid, topiramate, oxcarbazepine and clonazepam.